Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
RCT of the Cutting Balloon Versus a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses
This study is currently recruiting participants.
Verified by Henry Ford Health System, October 2007
Sponsors and Collaborators: Henry Ford Health System
Boston Scientific Corporation
Information provided by: Henry Ford Health System
ClinicalTrials.gov Identifier: NCT00543348
  Purpose

The proposed study will investigate the efficacy of the peripheral cutting balloon (PBC) compared to the high pressure balloon in dilating venous stenosis in hemodialysis fistulas.

2. SPECIFIC AIMS

Study endpoints will be:

Primary Endpoint

1. Primary and assisted patency at 6 months

Secondary Endpoints:

  1. Procedure effectiveness/residual stenosis
  2. Procedure-related complications
  3. Primary patency and primary assisted patency 12 months
  4. Secondary patency at 6 and 12 months
  5. Number/type of secondary interventions.

Condition Intervention
Stenosis
Procedure: CUTTING BALLOON ANGIOPLASTY
Procedure: HIGH PRESSURE BALLOON

MedlinePlus related topics: Angioplasty Fistulas
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Parallel Assignment, Safety/Efficacy Study
Official Title: A Randomised-Controlled Study Comparing the Peripheral Cutting BalloonTM (Boston Scientific Co.) With a High Pressure Balloon for the Treatment of Arteriovenous Fistula Stenoses

Further study details as provided by Henry Ford Health System:

Estimated Enrollment: 100
Study Start Date: September 2007
Arms Assigned Interventions
1: Active Comparator
CUTTING BALLOON
Procedure: CUTTING BALLOON ANGIOPLASTY
CUTTING BALLOON
2: Placebo Comparator Procedure: CUTTING BALLOON ANGIOPLASTY
CUTTING BALLOON
Procedure: HIGH PRESSURE BALLOON

  Eligibility

Ages Eligible for Study:   18 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Dysfunctional fistulas will be recruited based on the presence of clinical and hemodialysis parameters

Exclusion Criteria:

  • Arteriovenous prosthetic grafts
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00543348

Locations
United States, Michigan
Henry Ford Hospital Recruiting
DETROIT, Michigan, United States, 48202
Contact: GEORGES HADDAD, MD, FACS     313-916-7308     ghaddad1@hfhs.org    
Principal Investigator: GEORGES HADDAD, MD, FACS            
Sub-Investigator: STAVROS KAKKOS, MD, PhD            
Sponsors and Collaborators
Henry Ford Health System
Boston Scientific Corporation
Investigators
Principal Investigator: GEORGES HADDAD, MD, FACS Henry Ford Health System
  More Information

Study ID Numbers: HFHIRB4244
Study First Received: October 11, 2007
Last Updated: October 11, 2007
ClinicalTrials.gov Identifier: NCT00543348  
Health Authority: United States: Institutional Review Board

Keywords provided by Henry Ford Health System:
BALLOON ANGIOPLASTY
AUTOGENOUS FISTULA

Study placed in the following topic categories:
Pathological Conditions, Anatomical
Cardiovascular Abnormalities
Arteriovenous Fistula
Vascular Malformations
Vascular Diseases
Arteriovenous Malformations
Constriction, Pathologic
Congenital Abnormalities
Fistula

Additional relevant MeSH terms:
Vascular Fistula
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 15, 2009